HBEGF and breast cancer: We previously reported that PR SUMOylation is transcriptionally repressive at a limited number of endogenous gene loci, including HBEGF, IRS1, and STC1 [13,16]; all three gene products are known to contribute to breast cancer cell proliferation [72-74].